Latest tumor Stories
--Data Presented by Donald McDonald, UCSF, at the American Association for Cancer Research Meeting 2015-- SAN FRANCISCO, April 20, 2015 /PRNewswire/ -- SillaJen, Inc., a private clinical-stage
-- Animal model highly representative of late-stage ovarian cancer in women PHILADEPHIA, April 20, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen Ltd, (ASX:NRT;
- End of Dose-Escalation Confirmed - VANCOUVER, British Columbia and MENLO PARK, Calif., April 20, 2015 /PRNewswire/ -- DelMar
Clinical benefit fueling strong adoption in liquid biopsy market REDWOOD CITY, Calif.
SAN DIEGO, April 16, 2015 /PRNewswire/ -- Epic Sciences announced today that its no cell left behind(TM) technology has successfully integrated single cell isolation and downstream
SEATTLE, April 15, 2015 /PRNewswire/ -- Adaptive Biotechnologies, the company pioneering Next Generation Sequencing (NGS) applications for cancer immunology, and its collaborators will present
MADRID, April 14, 2015 /PRNewswire/ -- - Combination of the anticancer drug PM1183 with PARP inhibitors and doxorubicin results in a synergistic
Study Results Featured in Plenary Session at Society of Gynecologic Oncology Annual Meeting IRVING, Texas, March 30, 2015 /PRNewswire/ -- Caris Life Sciences® today announced the
Research Presented at the Society of Gynecologic Oncology 2015 Annual Meeting Suggest Treatment Options Based on Biomarker Profile May Result in Improved Outcomes IRVING, Texas, March
Research Provides Potential Implications for Immunotherapy in Treatment of Gynecologic Cancers IRVING, Texas, March 29, 2015 /PRNewswire/ -- Caris Life Sciences® today announced the
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.